{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:21:47Z","timestamp":1792718507673,"version":"4.5.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Aim:<\/jats:title>\n                    <jats:p>Precancer biomarkers help in early detection and management of oral potentially malignant disorders (OPMDs). Interleukin-1\u03b2 (IL-1\u03b2), a biomarker, is known to be altered in oral submucous fibrosis (OSMF) and oral leukoplakia (OL). Therefore, we evaluated and compared the serum and salivary IL-1\u03b2 levels in patients with OSMF\/oral leukoplakia and in gender- and age-matched healthy individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>An in vivo, prospective, observational study was conducted on 40 subjects. Subjects were divided into two groups with 20 individuals in each group, that is, Group I: OSMF\/oral leukoplakia and Group II: control group. Salivary and serum IL-1\u03b2 levels were quantitatively estimated using enzyme-linked immunosorbent assay (ELISA). The statistical tests used were unpaired t-test and Chi-square test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The serum IL-1\u03b2 levels were significantly (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      0.001) lesser in Group I in comparison to Group II. The salivary IL-1\u03b2 levels remained insignificant between both the groups. However, in both the groups, the salivary IL-1\u03b2 levels were significantly higher compared to the serum IL-1\u03b2 levels.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>We found that the serum IL-1\u03b2 level can be considered as a prospective biomarker for dysplasia, whereas salivary IL-1\u03b2 alone needs more elaborated studies to account for its application as a potential biomarker in OPMD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_2107_22","type":"journal-article","created":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T17:53:34Z","timestamp":1719510814000},"page":"788-792","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Serum and salivary interleukin-1\u03b2 level in oral precancer: An observational study"],"prefix":"10.4103","volume":"20","author":[{"given":"T Thamarai","family":"Selvan","sequence":"first","affiliation":[{"name":"Department of Oral Medicine and Radiology, Faculty of Dental Sciences, King George\u2019s Medical University (KGMU), Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit K.","family":"Patil","sequence":"additional","affiliation":[{"name":"Department of Oral Medicine and Radiology, Faculty of Dental Sciences, King George\u2019s Medical University (KGMU), Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Oral Medicine and Radiology, Faculty of Dental Sciences, King George\u2019s Medical University (KGMU), Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Verma","sequence":"additional","affiliation":[{"name":"Department of Health Research- Multi-Disciplinary Research Unit (DHR-MRU), King George\u2019s Medical University (KGMU), Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anurag","family":"Tripathi","sequence":"additional","affiliation":[{"name":"Department of Oral Medicine and Radiology, Faculty of Dental Sciences, King George\u2019s Medical University (KGMU), Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Khanna","sequence":"additional","affiliation":[{"name":"Department of Oral Medicine and Radiology, Faculty of Dental Sciences, King George\u2019s Medical University (KGMU), Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhilanand","family":"Chaurasia","sequence":"additional","affiliation":[{"name":"Department of Oral Medicine and Radiology, Faculty of Dental Sciences, King George\u2019s Medical University (KGMU), Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akanksha G.","family":"Shetye","sequence":"additional","affiliation":[{"name":"Department of Prosthodontics and Crown & Bridge, Faculty of Dental Sciences, King George\u2019s Medical University (KGMU), Lucknow, Uttar Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,5,2]]},"reference":[{"key":"R1-20241021","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12663-011-0195-z","article-title":"Oral cancer: Risk factors and molecular pathogenesis","volume":"10","author":"Ram","year":"2011","journal-title":"J Maxillofac Oral Surg"},{"key":"R2-20241021","first-page":"867","article-title":"The changing epidemiology of oral cancer: Definitions, trends, and risk factors","volume":"225","author":"Conway","year":"2018","journal-title":"Nat Publ Gr"},{"key":"R3-20241021","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cden.2019.08.004","article-title":"Oral potentially malignant disorders","volume":"64","author":"Wetzel","year":"2020","journal-title":"Dent Clin North Am"},{"key":"R4-20241021","doi-asserted-by":"crossref","first-page":"866","DOI":"10.12998\/wjcc.v2.i12.866","article-title":"Precancerous lesions of oral mucosa","volume":"2","author":"Yardimci","year":"2014","journal-title":"World J Clin Cases"},{"key":"R5-20241021","first-page":"399","article-title":"An update on studies on etiological factors, disease progression, and malignant transformation in oral submucous fibrosis","volume":"13","author":"Bari","year":"2017","journal-title":"J Cancer Res Ther"},{"key":"R6-20241021","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4103\/0019-509X.134651","article-title":"Epidemiology, control and prevention of tobacco induced oral mucosal lesions in India","volume":"51","author":"Sridharan","year":"2014","journal-title":"Indian J Cancer"},{"key":"R7-20241021","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bjoms.2012.08.014","article-title":"Oral submucous fibrosis: An overview of the aetiology, pathogenesis, classification and principles of management","volume":"51","author":"Arakeri","year":"2013","journal-title":"Br J Oral Maxillofac Surg"},{"key":"R8-20241021","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10006-010-0209-x","article-title":"Management of oral submucous fibrosis: An overview","volume":"14","author":"Angadi","year":"2010","journal-title":"Oral Maxillofac Surg"},{"key":"R9-20241021","first-page":"163","article-title":"Aetiology of oral submucous fibrosis: The stimulation of collagen synthesis by extracts of areca nut","volume":"10","author":"Canniff","year":"1981","journal-title":"Int J Oral Surg"},{"key":"R10-20241021","first-page":"002","article-title":"Oral submucous fibrosis: Review on mechanisms of pathogenesis and malignant transformation","volume":"S5","author":"Ekanayaka","year":"2013","journal-title":"J Carcinogene Mutagene"},{"key":"R11-20241021","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jobcr.2020.08.004","article-title":"Medicinal management of oral submucous fibrosis in the past decade- A systematic review","volume":"10","author":"More","year":"2020","journal-title":"J Oral Biol Craniofacial Res"},{"key":"R12-20241021","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1586\/14737140.2013.842898","article-title":"Management for premalignant lesions of the oral cavity","volume":"14","author":"Panwar","year":"2014","journal-title":"Expert Rev Anticancer Ther"},{"key":"R13-20241021","first-page":"88","article-title":"Oral leukoplakia-an update","volume":"9","author":"Parlatescu","year":"2014","journal-title":"Maedica (Bucur)"},{"key":"R14-20241021","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.oooo.2016.08.021","article-title":"Screening for oral cancer\u2014A perspective from the global oral cancer forum","volume":"123","author":"Speight","year":"2017","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"R15-20241021","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4103\/0976-433X.145159","article-title":"Role of cytokines in oral malignancies","volume":"5","author":"Unus","year":"2014","journal-title":"SRM J Res Dent Sci"},{"key":"R16-20241021","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.4317\/medoral.17323","article-title":"Salivary and serum interleukin 1 beta, interleukin 6 and tumor necrosis factor alpha in patients with leukoplakia and oral cancer","volume":"17","author":"Brailo","year":"2012","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"R17-20241021","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1007\/s00018-019-03351-7","article-title":"Tumor angiogenesis: Causes, consequences, challenges and opportunities","volume":"77","author":"Lugano","year":"2020","journal-title":"Cell. Mol. Life Sci"},{"key":"R18-20241021","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1006\/cyto.1997.0342","article-title":"Immunolocalization of cytokines and growth factors in oral submucous fibrosis","volume":"10","author":"Haque","year":"1998","journal-title":"Cytokine"},{"key":"R19-20241021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/froh.2021.649406","article-title":"Expression of interleukin-1? and interleukin-8 in oral potentially malignant disorders and carcinomas","volume":"2","author":"Lopez-Labady","year":"2021","journal-title":"Front Oral Health"},{"key":"R20-20241021","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1021\/pr070529w","article-title":"Body fluid proteomics for biomarker discovery: Lessons from the past hold the key to success in the future","volume":"6","author":"Good","year":"2007","journal-title":"J Proteome Res"},{"key":"R21-20241021","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4103\/ejd.ejd_183_17","article-title":"Human salivary protein extraction from RNAPro\u00b7SAL\u2122, Pure\u00b7SAL\u2122and passive drooling method","volume":"11","author":"Khurshid","year":"2017","journal-title":"Eur J Dent"},{"key":"R22-20241021","doi-asserted-by":"crossref","first-page":"398","DOI":"10.4103\/jpbs.JPBS_751_20","article-title":"Prevalence and risk factors for oral potentially malignant disorders in Indian population","volume":"13","author":"Singh","year":"2021","journal-title":"J Pharm Bioall Sci"},{"key":"R23-20241021","first-page":"175","article-title":"The effects of arecoline on the release of cytokines using cultured peripheral blood mononuclear cells from patients with oral mucous diseases","volume":"17","author":"Hsu","year":"2001","journal-title":"Kaohsiung J Med Sci"},{"key":"R24-20241021","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1006\/cyto.2001.0863","article-title":"Expression of IL-1 beta and IL-8 by human gingival epithelial cells in response to Actinobacillus actinomycetemcomitans","volume":"14","author":"Uchida","year":"2001","journal-title":"Cytokine"},{"key":"R25-20241021","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0714.2007.00584.x","article-title":"Oral epithelial dysplasia classification systems: Predictive value, utility, weaknesses and scope for improvement","volume":"37","author":"Warnakulasuriya","year":"2008","journal-title":"J Oral Pathol Med"},{"key":"R26-20241021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","article-title":"Cytokines, inflammation, and pain","volume":"45","author":"Zhang","year":"2007","journal-title":"Int Anesthesiol Clin"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2107_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:38:44Z","timestamp":1787067524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_2107_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,2]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_2107_22","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,2]]},"assertion":[{"value":"2022-10-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-11-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}